Back

Short-term effects on sacubitril/valsartan therapy on right ventricle work and mechanics in patients with heart failure and reduced ejection fraction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Heart failure: drug therapy and multidisciplinary care Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Joonas Ottela

Turku University Hospital, Turku (Finland)

6 More presentations in this session

Presentation thumbnail
Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction
Doctor S. Matsumoto (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Systematic review and meta-analysis on the effects of physical activity-based interventions on frailty status and clinical outcomes in adults with long-term cardiac conditions.
Ms H. Waterhouse (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Assessing the practicality of a novel heart failure therapeutic score (QUAD Score) for drug optimisation in heart failure with a reduced ejection fraction
Doctor A. Ganapathy (Basildon, GB)
Abstract Slides Video
Presentation thumbnail
Cardiovascular mortality with oral potassium-binders in patients with CKD and heart failure
Doctor H. Barzkar (Dallas, US)
Abstract Slides Video
Presentation thumbnail
The effects of angiotensin receptor-neprilysin inhibitors on clinical outcomes in heart failure with mildly reduced or preserved ejection fraction: real-world evidence from the CCA Database-HF Center
Doctor Z. Xie (Shanghai, CN) Professor J. Zhou (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: drug therapy and multidisciplinary care

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Treatment with sacubitril/valsartan and improvement of ventricular-arterial coupling in heart failure with reduced ejection fraction
thumbnail
Congress Presentation
A meta-analysis of the effects of sacubitril-valsartan on surrogate markers of systemic right ventricular dysfunction in congenital heart disease
thumbnail
Congress Presentation
Heterogeneity in the response to angiotensin receptor-neprilysin inhibitors on ventricular arrhythmogenicity and sympathetic tone activation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources